Boshi Pharmaceuticals: Controlling shareholder plans to reduce its holdings by 3.00% within three months.

Boji Pharmaceuticals announcement, the controlling shareholder Wang Tingchun and the concerted action person Fermi 13 plan to reduce their holdings by a total of no more than 11.48 million shares, or 3.00% of the total shares, through block trades or centralized bidding from September 12, 2025 to December 11, 2025. Among them, Fermi No. 13 plans to reduce holdings by 1.7079 million shares through block trades and 3.8288 million shares through centralized bidding, while Wang Tingchun plans to reduce holdings by 5.9498 million shares through block trades.